AI assistant
Sending…
Pacira BioSciences, Inc. — Director's Dealing 2013
Sep 14, 2013
32125_dirs_2013-09-13_54f314d5-c52e-4b5a-b084-958a942ddff5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Pacira Pharmaceuticals, Inc. (PCRX)
CIK: 0001396814
Period of Report: 2013-09-11
Reporting Person: WINGER DENNIS L (Director)
More from Pacira BioSciences, Inc.
Proxy Solicitation & Information Statement
2026
Jun 4
Proxy Solicitation & Information Statement
2026
Jun 1
Proxy Solicitation & Information Statement
2026
May 28
Proxy Solicitation & Information Statement
2026
May 27
Proxy Solicitation & Information Statement
2026
May 26
Proxy Solicitation & Information Statement
2026
May 20
Proxy Solicitation & Information Statement
2026
May 19
Proxy Solicitation & Information Statement
2026
May 13
Proxy Solicitation & Information Statement
2026
May 12
Interim / Quarterly Report
2026
Apr 30